Procept Biorobotics Return On Asset vs. Gross Profit

PRCT Stock  USD 95.59  1.70  1.75%   
Based on Procept Biorobotics' profitability indicators, Procept Biorobotics Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Procept Biorobotics' ability to earn profits and add value for shareholders.
For Procept Biorobotics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Procept Biorobotics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Procept Biorobotics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Procept Biorobotics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Procept Biorobotics Corp over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procept Biorobotics. If investors know Procept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procept Biorobotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Procept Biorobotics Corp is measured differently than its book value, which is the value of Procept that is recorded on the company's balance sheet. Investors also form their own opinion of Procept Biorobotics' value that differs from its market value or its book value, called intrinsic value, which is Procept Biorobotics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procept Biorobotics' market value can be influenced by many factors that don't directly affect Procept Biorobotics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procept Biorobotics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Procept Biorobotics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procept Biorobotics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Procept Biorobotics Corp Gross Profit vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Procept Biorobotics's current stock value. Our valuation model uses many indicators to compare Procept Biorobotics value to that of its competitors to determine the firm's financial worth.
Procept Biorobotics Corp is rated below average in return on asset category among its peers. It also is rated below average in gross profit category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Procept Biorobotics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Procept Gross Profit vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Procept Biorobotics

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.17
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Procept Biorobotics

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
37.09 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Procept Gross Profit Comparison

Procept Biorobotics is currently under evaluation in gross profit category among its peers.

Procept Biorobotics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Procept Biorobotics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Procept Biorobotics will eventually generate negative long term returns. The profitability progress is the general direction of Procept Biorobotics' change in net profit over the period of time. It can combine multiple indicators of Procept Biorobotics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. Procept Biorobotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 234 people.

Procept Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Procept Biorobotics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Procept Biorobotics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Procept Biorobotics' important profitability drivers and their relationship over time.

Use Procept Biorobotics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Procept Biorobotics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procept Biorobotics will appreciate offsetting losses from the drop in the long position's value.

Procept Biorobotics Pair Trading

Procept Biorobotics Corp Pair Trading Analysis

The ability to find closely correlated positions to Procept Biorobotics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Procept Biorobotics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Procept Biorobotics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Procept Biorobotics Corp to buy it.
The correlation of Procept Biorobotics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Procept Biorobotics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Procept Biorobotics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Procept Biorobotics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Procept Biorobotics position

In addition to having Procept Biorobotics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling
Gambling Theme
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.